2024-03-29T12:50:41Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_1366E167CF80
2024-03-23T01:52:44Z
serval:BIB_1366E167CF80
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease
9176073
A1997WX46800008
J.
Bauditz
author
J.
Haemling
author
M.
Ortner
author
H.
Lochs
author
A.
Raedler
author
S.
Schreiber
author
article
1997-04
Gut
0017-5749
journal
40
4
470-4
Adult
Anti-Inflammatory Agents/*therapeutic use
Cells, Cultured
Chronic Disease
Crohn Disease/*drug therapy/immunology
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Leukocytes, Mononuclear/drug effects/immunology
Lipopolysaccharides/pharmacology
Male
Middle Aged
Pentoxifylline/*therapeutic use
Phosphodiesterase Inhibitors/*therapeutic use
Prednisolone/*therapeutic use
Treatment Failure
Tumor Necrosis Factor-alpha/*antagonists & inhibitors/secretion
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Apr
60_published